Thermo Fisher Scientific reported $5.5B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agilent USD 1.09B 30M Mar/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Bio Techne USD 201.18M 4.27M Mar/2026
Bio-Rad Laboratories USD 780.6M 10.1M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Bruker USD 1.12B 1.4M Jun/2026
Charles River Laboratories USD 346.26M 13.46M Jun/2026
Danaher USD 3.26B 652M Jun/2026
Dentsply International USD 665M 6M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
General Electric Aerospace USD 12.44B 73M Jun/2026
Henry Schein USD 2.06B 45M Jun/2026
Illumina USD 629M 18M Jun/2026
Intuitive Surgical USD 2.03B 83.6M Jun/2026
Laboratory Of America USD 562.2M 64.5M Jun/2026
Medtronic USD 6.31B 153M Dec/2025
Mettler Toledo International USD 411.56M 6.74M Jun/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
Olympus JPY 208.61B 5.07B Sep/2025
OraSure Technologies USD 30.07M 236K Jun/2026
Quest Diagnostics USD 233M 8M Jun/2026
Repligen USD 186.6M 7.35M Jun/2026
Revvity USD 378.5M 9M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 22.66M 1.24M Jun/2026
Waters USD 1.38B 119M Jun/2026
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026